Patents by Inventor Ganesh Bhaskarrao Shete

Ganesh Bhaskarrao Shete has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORAL PHARMACEUTICAL COMPOSITION OF METHYLERGONOVINE AND METHODS OF USE THEREOF
    Publication number: 20180116953
    Abstract: A solid pharmaceutical oral composition once or twice daily administration is provided. The composition includes an immediate release core comprising methylergonovine or a pharmaceutically acceptable salt thereof, and a polymer coating disposed on the immediate release core. The composition comprises from about 0.3 mg to about 0.8 mg in total of methylergonovine or a pharmaceutically acceptable salt thereof. The composition is used for treating a subject having a methylergonovine responsive condition such as migraine, refractory migraine, uterine atony, uterine haemorrhage, subinvolution of the uterus, and uterine haemorrhage in the second stage of labor.
    Type: Application
    Filed: November 22, 2017
    Publication date: May 3, 2018
    Applicant: Lupin Atlantis Holdings SA
    Inventors: James Allen Garegnani, Makarand Krishnakumar Avachat, Sajeev Chandran, Ashish Ashokrao Deshmukh, Ganesh Bhaskarrao Shete
  • ORAL PHARMACEUTICAL COMPOSITION OF METHYLERGONOVINE AND METHODS OF USE THEREOF
    Publication number: 20180116952
    Abstract: A solid pharmaceutical oral composition for once or twice daily administration is provided. The composition includes pulsed release pellets. Each pellet includes at least a first drug layer comprising methylergonovine or a pharmaceutically acceptable salt thereof, and a second drug layer comprising methylergonovine or a pharmaceutically acceptable salt thereof. The solid pharmaceutical oral composition includes from about 0.3 mg to about 0.8 mg in total of methylergonovine or a pharmaceutically acceptable salt thereof. The composition is used for treating a subject having a methylergonovine responsive condition such as migraine, refractory migraine, uterine atony, uterine haemorrhage, subinvolution of the uterus, and uterine haemorrhage in the second stage of labor.
    Type: Application
    Filed: November 22, 2017
    Publication date: May 3, 2018
    Applicant: LUPIN ATLANTIS HOLDINGS SA
    Inventors: James Allen Garegnani, Makarand Krishnakumar Avachat, Sajeev Chandran, Ashish Ashokrao Deshmukh, Ganesh Bhaskarrao Shete
  • ORAL PHARMACEUTICAL COMPOSITION OF METHYLERGONOVINE AND METHODS OF USE THEREOF
    Publication number: 20180098942
    Abstract: A solid pharmaceutical oral composition for twice daily administration is provided. The composition includes from about 0.3 mg to about 0.6 mg in total of methylergonovine or a pharmaceutically acceptable salt thereof. The composition is used for treating a subject having a methylergonovine responsive condition such as migraine, refractory migraine, uterine atony, uterine haemorrhage, subinvolution of the uterus, and uterine haemorrhage in the second stage of labor.
    Type: Application
    Filed: November 22, 2017
    Publication date: April 12, 2018
    Applicant: Lupin Atlantis Holdings SA
    Inventors: James Allen Garegnani, Makarand Krishnakumar Avachat, Sajeev Chandran, Ashish Ashokrao Deshmukh, Ganesh Bhaskarrao Shete
  • ORAL PHARMACEUTICAL COMPOSITION OF METHYLERGONOVINE AND METHODS OF USE THEREOF
    Publication number: 20180098982
    Abstract: A solid pharmaceutical oral composition for once daily administration is provided. The composition includes from about 0.5 mg to about 0.8 mg in total of methylergonovine or a pharmaceutically acceptable salt thereof. The composition is used for treating a subject having a methylergonovine responsive condition such as migraine, refractory migraine, uterine atony, uterine haemorrhage, subinvolution of the uterus, and uterine haemorrhage in the second stage of labor.
    Type: Application
    Filed: November 22, 2017
    Publication date: April 12, 2018
    Applicant: LUPIN ATLANTIS HOLDINGS SA
    Inventors: James Allen Garegnani, Makarand Krishnakumar Avachat, Sajeev Chandran, Ashish Ashokrao Deshmukh, Ganesh Bhaskarrao Shete